Silicon-Based Nanoparticles for Cancer Therapy and Bioimaging

Nanotechnology has emerged, particularly in the realm of reducing mortality worldwide. Despite advancements in conventional treatment methods such as chemotherapy, radiotherapy, and surgery, challenges related to drug delivery, tumor targeting, and the prevention of side effects remain significant. This is where nanotechnology, especially silicon-based nanoparticles, holds immense potential. These minuscule materials are designed to interact with diagnosing and treating cancer. Nanoparticles, size, chemical, pharmacokinetics, anticancer. Traditional chemotherapeutic drugs often have low bioavailability and non-specific distribution in the body, leading to systemic toxicity and limited efficacy. Silicon-based nanoparticles, however, are unique. They can be engineered to encapsulate chemotherapeutic drugs, enabling the maximization of the side effects. Silicon, an abundant and relatively non-toxic element, is well tolerated by humans.